Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases 1R03AR086904-01
Modifying bone morphogenetic protein 9 (BMP9) signaling in secondary lymphedema
Recipient
Brigham and Women's Hospital
Award Amount
$151,950.00
Ceiling
$151,950.00
Awarded
July 20, 2026
Identifier
1R03AR086904-01
NIH awarded a grant to Brigham and Women's Hospital to study BMP9 signaling in secondary lymphedema to develop new treatments.
Description
This NIH R03 project focuses on understanding and modifying BMP9 signaling to develop new treatments for secondary lymphedema, a condition affecting millions of cancer patients in the U.S. The project aims to investigate how BMP9 signaling influences lymphatic function and development, with the goal of developing therapeutic strategies.